José Luis Ramírez
Universidad Autónoma Metropolitana(MX)Instituto de Estudios Avanzados(VE)University of Castilla-La Mancha(ES)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, Epigenetics and DNA Methylation, RNA modifications and cancer, Lung Cancer Research Studies
Most-Cited Works
- → Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial(2012)5,500 cited
- → The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies(2015)552 cited
- → Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC(2017)216 cited
- → Molecular karyotype of clone CL Brener chosen for the Trypanosoma cruzi Genome Project(1995)150 cited
- O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme.(2003)
- → 14-3-3σ Methylation in Pretreatment Serum Circulating DNA of Cisplatin-Plus-Gemcitabine-Treated Advanced Non–Small-Cell Lung Cancer Patients Predicts Survival: The Spanish Lung Cancer Group(2005)121 cited